Central Florida Pulmonary Group

Orlando, Florida 32803-5734

5 studies enrolling now · 29 studies all time

What they study most

Bronchiectasis, Cancer, Cardiovascular Diseases, Central Sleep Apnea, Chronic Obstructive Pulmonary Disease, Chronic Pseudomonas Aeruginosa Infection, Connective Tissue Diseases, Covid19, Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation, Exocrine Pancreatic Insufficiency

Studies at this site

• Phase 2 Study to Assess the Safety and Efficacy of ANG003 — Recruiting now
• A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) — Recruiting now
• A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators — Recruiting now
• Study With Phage for CF Subjects With Pseudomonas Lung Infection — Recruiting now
• LYT-100 in Post-acute COVID-19 Respiratory Disease — Stopped early
• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients — Completed
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension — Enrolling by invitation
• Development and Validation of Harbinger Health Test for Early Cancer Detection — Completed
• remedē System Therapy Study — Running, not enrolling
• Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection — Completed
• A Registry for Patients Taking Uptravi — Completed
• Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy — Completed
• Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study — Completed
• Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study — Completed
• Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis — Completed
• Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations — Withdrawn before enrolling
• Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection — Stopped early
• AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis — Completed
• A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis — Completed
• A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis — Completed
• A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) — Completed
• Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients — Completed
• A Study to Evaluate Safety, Efficacy, and Tolerability of TEZ/IVA in Orkambi® (Lumacaftor/Ivacaftor) -Experienced Subjects With Cystic Fibrosis (CF) — Completed
• EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients — Completed
• A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis — Completed
• Long-term Oxygen Treatment Trial — Completed
• Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis — Completed
• Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis — Completed
• Iloprost Power Disc-15 in Pulmonary Arterial Hypertension — Stopped early